At NOVAiCOS ImmunoTherapeutics, our mission is to revolutionize the treatment of bone-loss-related diseases, including bone tumors, through an innovative biotechnological platform based on immunotherapy.

We develop cutting-edge therapeutic solutions, leveraging our patented immune-derived compound, ICOS-Fc, the first immunotherapic able to contemporary modulate immune system and inhibit bone erosion and tumor growth in conditions such as...